New radioactive compound shows promise in first human tests for Hard-to-Treat cancers
NCT ID NCT07299253
First seen Jan 04, 2026 · Last updated May 25, 2026 · Updated 23 times
Summary
This early study tested a new radioactive drug called [177Lu]Lu-TEFAPI-06 in 5 adults with advanced solid tumors that had spread and were no longer responding to standard treatments. The main goal was to check safety and see where the drug goes in the body. Researchers also looked at whether it could help shrink tumors. The drug targets a protein (FAP) found in many cancer types, aiming to deliver radiation directly to cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMORS (ANY LOCALIZATION) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Hospital & Clinical Medical School, Lanzhou University
Lanzhou, Gansu, 730000, China
Conditions
Explore the condition pages connected to this study.